|
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation of oral care...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
Medactive : Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation of oral care...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
- Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation of oral care...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supp
Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation of oral care...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with
BusinessWire - Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
SPRING HILL, Fla.--(BUSINESS WIRE)-- Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
SPRING HILL, Fla.(Business Wire) -- Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc. that provides Medactive exclusive rights to produce and...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
SPRING HILL, Fla.--(BUSINESS WIRE)--Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and market a new generation of oral care...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
Pact Paves Way for Patient-Friendly MedActive Oral Care Products Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
SPRING HILL, Fla.--(BUSINESS WIRE)--Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies, Inc.that provides Medactive exclusive rights to produce and...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License and Supply Agreement with WhiteHill Oral Tech
Pact Paves Way for Patient-Friendly" MedActive Oral Care Products SPRING HILL, Fla.--(BUSINESS WIRE)--Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral Technologies,...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License And Supply Agreement With WhiteHill Oral Tech
Pact paves way for 'Patient-Friendly"' MedActive Oral Care Products.Spring Hill, FL (PRWEB) June 29, 2009 -- Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral...
|
|
|
Medactive Oral Pharmaceuticals, LLC. Announces Exclusive License And Supply Agreement With WhiteHill Oral Tech
Pact paves way for 'Patient-Friendly' MedActive Oral Care Products.Spring Hill, FL (PRWEB) June 29, 2009 -- Medactive Oral Pharmaceuticals, LLC, announced today that it has entered into a License/Supply Agreement with WhiteHill Oral...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its By
Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States Food and Drug...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shareholders Meeting to Amend It
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States Food and Drug Administration (FDA)...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shareholders Meeting to Amend It
Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States Food and Drug...
|
|
|
BioAlliance Pharma Submits Loramyc(R) NDA to US FDA
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United...
|
|
|
Bioalliance Pharma Submits Loramyc(R) NDA to US FDA And Announces a General Shareholders'
BusinessWire - Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General ShareholdersEUR Meeting to
Regulatory News.BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States Food and Drug...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General
Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the United States Food and Drug...
|
|
|
Bioalliance Pharma Submits Loramyc(R) NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris: BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the...
|
|
|
Bioalliance Pharma Submits Loramyc(R) NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris: BIO), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its B
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO - News), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the...
|
|
|
Bioalliance Pharma Submits Loramyc NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its B
PARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO - News), a company dedicated to the treatment of cancer and AIDS patients and supportive care, today announced the submission of its New Drug Application (NDA) to the...
|
